首页> 外文期刊>European Journal of Cancer Supplements >403 POSTER The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover in osseous metastatic breast cancer while osteocalcin and CTX show inferior monitoring performance

【24h】

403 POSTER The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover in osseous metastatic breast cancer while osteocalcin and CTX show inferior monitoring performance

机译：403海报I型胶原蛋白的氨基末端前肽（PINP）是骨转移性乳腺癌中骨转换的临床有效指标，而骨钙蛋白和CTX的监测性能较差

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2005年第2期|共2页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献

1. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer. [J] . Pollmann D, Siepmann S, Geppert R, Anticancer Research: International Journal of Cancer Research and Treatment . 2007,第4Appa期

机译：I型胶原的氨基末端前肽（PINP）是骨转移性乳腺癌中骨转换和转移扩散程度的临床有效指标。
2. A role for bone turnover markers beta-CrossLaps (CTX) and amino-terminal propeptide of type I collagen (PINP) as potential indicators for disease progression from MGUS to multiple myeloma [J] . Vallet Sonia, Hoyle Nicholas R., Kyle Robert A., Leukemia and lymphoma . 2018,第9a10期

机译：骨质周转标记（CTX）和I型胶原蛋白（PINP）的氨基末端的作用是I型胶原（PINP）的潜在指标从MGU到多发性骨髓瘤的潜在指标
3. Carboxy-terminal telopeptide (CTX) and amino-terminal propeptide (PINP) of type I collagen as markers of bone metastases in patients with non-small cell lung cancer. [J] . Franco Lumachi, Davide A Santeufemia, Alessandro Del Conte, Anticancer Research: International Journal of Cancer Research and Treatment . 2013,第6期

机译：I型胶原的羧基末端端肽（CTX）和氨基末端前肽（PINP）作为非小细胞肺癌患者骨转移的标志物。
4. Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast cancer patients. [O] . T. Saarto, C. Blomqvist, J. Risteli, 1998

机译：I型胶原原的氨基末端前肽（PINP）与骨丢失有关并预测了绝经前后非转移性乳腺癌患者的抗吸收疗法的疗效。
5. Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast cancer patients. [O] . Saarto, T., Blomqvist, C., Risteli, J., 1998

机译：I型胶原原的氨基末端前肽（PINP）与骨丢失有关，并预测了绝经前后非转移性乳腺癌患者的抗吸收疗法的疗效。

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号